Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
ASD clinical trials
Every US clinical trial registered for ASD — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
8 US clinical trials · 4 currently recruiting
The research picture
ASD has 8 registered US clinical trials, 4 of them open to new participants right now — about 50% of the total.
- 4
- recruiting participants now
- 50%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Joanne Kurtzberg, MD
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Boston Children's Hospital
NCT02461446
Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism
Stanford University
NCT04899544
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Adia Med of Winter Park
NCT07304440
A Phase 2A Trial of MM402 for Autism Spectrum Disorder
Definium Therapeutics US
NCT07303907
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
Children's Hospital Medical Center, Cincinnati
NCT06670040
Cord Blood Infusion for Children With Autism Spectrum Disorder
Joanne Kurtzberg, MD
NCT02847182
Cannabidiol for ASD Open Trial
NYU Langone Health
NCT03900923
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Massachusetts General Hospital
NCT01931033
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the ASD Trial Landscape
ClinicalTrials.gov lists 8 US studies indexed under ASD, and 4 of those are currently open to recruitment — roughly 50% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for ASD shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for ASD is led by Joanne Kurtzberg, MD with 1 indexed trial, alongside 7 other organizations in the top contributor list. The list on this page surfaces up to 8 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for ASD?
PlainTrial tracks 8 US clinical trials for ASD, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for ASD?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.